LAMP
The pharmaceutical firm said the decision was related to the cost associated with the molecular tests.
The molecular test is used to differentiate bacterial infections, viral infections, and noninfectious disease and to assess the risk that patients will develop severe illness.
Inflammatix Raises $57M in Series E Financing
The company said that it will use the money to support regulatory filings and commercialization of its 30-minute TriVerity Acute Infection and Sepsis Test.
The Paris-based startup plans to use €1.5 million in pre-seed funding to support R&D on a test kit and deliver preclinical data by early 2025.
Startup En Carta Gets €1.5M for Development of Lyme Disease Test
The Paris-based firm will use the money to support the development of its Lyme disease test kit that will be used for early detection following a tick bite.
Jan 31, 2024
Dec 11, 2023
Nov 28, 2023
Oct 11, 2023
Sep 14, 2023
Apr 27, 2023
Apr 21, 2023